biology

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines

Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’

On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, cal

AgBiome lands $116M for safer crop protection technology

The company captures diverse microbes for agricultural applications, like crop protection, and screens strains for the best assays that would work for insect, disease and nematode control.

Personalized nutrition startup Zoe closes out Series B at $53M total raise

Personalized nutrition startup Zoe — named not for a person but after the Greek word for ‘life’ — has topped up its Series B round with $20M, bringing the total raised to $53M.

I can’t believe it’s not meat! Mycelium meat replacement company aims for summer launch of first products

Meati, a company turning mycelium (the structural fibers of fungi) into healthier meat replacements for consumers, is prepping for a big summer rollout. Co-founder Tyler Huggins expects to have the fi

Mercado Libre taps Pachama to monitor and manage its $8 million investment in Latin American rainforest restoration

Mercado Libre, one of the largest e-commerce and financial services company from Latin America by market cap, has selected the startup and Y Combinator alumni Pachama as its strategic partner in devel

New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology

Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Based in North Carolin

Senti Bio raises $105 million for its new programmable biology platform and cancer therapies

Senti Biosciences, a company developing cancer therapies using a new programmable biology platform, said it has raised $105 million in a new round of financing led by the venture arm of life sciences

23andMe raises $82.5 million in new funding

DNA testing technology company 23andMe has raised just shy of $82.5 million in new funding, from an offering of $85 million in total equity shares, according to a new SEC filing. The funding, confirme

Poland’s GeneMe secures €5.2M seed funding for its rapid COVID-19 test

GeneMe, Poland-based biotechnology company with a COVID-19 test, has secured a €5.2 million round of seed funding led by Robin Tombs, co-founder of Yoti and previously of Gamesys, and other angel in

John Legend and Natalie Portman want you to try wearing fungus instead of leather

Natalie Portman and John Legend are joining a group of venture capitalists and unnamed fashion brands backing MycoWorks, a company that just raised $45 million to commercialize its technology that mak

Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day

Biotech can often, and sometimes literally, fly over our heads. However, the pandemic has shown an increased need for investment and focus on solutions that work on human and planetary health. For Ind

Nobel laureate Jennifer Doudna shares her perspective on COVID-19 and CRISPR

CRISPR co-discoverer Jennifer Doudna was named a Nobel laureate in Chemistry today, sharing the honour with Emmanuelle Charpentier. We had the opportunity to speak to Doudna recently at our TechCrunch

Scribe Therapeutics launches a platform for engineering CRISPR-based therapeutics

A new company called Scribe Therapeutics founded by two former members of CRISPR pioneer Jennifer Doudna’s UC Berkeley genetics lab (alongside Doudna herself) launched on Tuesday, debuting a pla

Ansa Biotechnologies wants to usher in a new era of DNA manufacturing

Daniel Arlow has spent the last eighteen years studying genomics and synthetic biology. The arc of his career has taken the first-time founder of the new startup Ansa Biotechnologies from MIT to the f

This looping aquatic treadmill lets tiny ocean creatures swim forever under the microscope

Observing the microscopic creatures that fill our oceans is important work, but keeping your eye on one in the wild is practically impossible — and doing so in a dish isn’t the same. This &#82

Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies

California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participation from Soleus Capital and existing investors Mayfield, Cota and A

Mammoth Biosciences lands exclusive license to new CRISPR proteins that could boost gene editing precision

CRISPR pioneer Mammoth Biosciences has secured an exclusive license to a new family of CRISPR proteins. Obtained from UC Berkeley, the license covers R&D and commercialization across all potential

Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH funding through RADx program

CRISPR tech startup Mammoth Biosciences is among the companies that revealed backing from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) program on Friday. Mammoth re

Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Ori
Load More